IL1B and plasma cell myeloma: The cancer‐suppressive effect of IL‐1β was confirmed in a mouse model for myeloma showing that IL‐1β (as well as IL‐1α) neutralization by anakinra severely impaired myeloma clearance by tumor‐specific Th1 cells and tumor‐infiltrating macrophages.162